Provectus Biopharmaceuticals annual free cash flow
2009
2011
2012
2013
2014
2015
2017
Provectus Biopharmaceuticals Free Cash Flow (FCF) History (PVCT)
Provectus Biopharmaceuticals reported −$10.4M in free cash flow for fiscal 2017, an increase of $7.0M from the previous fiscal year.
View full Provectus Biopharmaceuticals company overviewProvectus Biopharmaceuticals free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2017 | 2017-12-31 | −$10.4M | $7.0M | — | — |
| 2015 | 2015-12-31 | −$17.4M | −$3.5M | — | — |
| 2014 | 2014-12-31 | −$13.9M | −$4.0M | — | — |
| 2013 | 2013-12-31 | −$9.9M | $1.4M | — | — |
| 2012 | 2012-12-31 | −$11.3M | $5.9M | — | — |
| 2011 | 2011-12-31 | −$17.2M | −$8.6M | — | — |
| 2009 | 2009-12-31 | −$8.6M | — | — | — |
Provectus Biopharmaceuticals quarterly free cash flow
Q3.11
Q1.12
Q2.12
Q3.12
Q4.12
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q4 2012 | 2012-12-31 | −$3.3M | $437,375 | — | — |
| Q3 2012 | 2012-09-30 | −$2.2M | — | — | — |
| Q2 2012 | 2012-06-30 | −$2.9M | — | — | — |
| Q1 2012 | 2012-03-31 | −$2.8M | — | — | — |
| Q3 2011 | 2011-09-30 | −$3.8M | — | — | — |
Provectus Biopharmaceuticals free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from −$17.2M to −$10.4M, a net increase of $6.8M. Provectus Biopharmaceuticals's latest reported quarter, Q4 2012, generated −$3.3M in free cash flow, an increase of $437,375 year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Provectus Biopharmaceuticals filings at SEC.gov ↗